Literature DB >> 15118085

Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs.

Stephan W Lindemann1, Christian C Yost, Melvin M Denis, Thomas M McIntyre, Andrew S Weyrich, Guy A Zimmerman.   

Abstract

The mechanisms by which neutrophils, key effector cells of the innate immune system, express new gene products in inflammation are largely uncharacterized. We found that they rapidly translate constitutive mRNAs when activated, a previously unrecognized response. One of the proteins synthesized without a requirement for transcription is the soluble IL-6 receptor alpha, which translocates to endothelial cells and induces a temporal switch to mononuclear leukocyte recruitment. Its synthesis is regulated by a specialized translational control pathway that is inhibited by rapamycin, a bacterial macrolide with therapeutic efficacy in transplantation, inflammatory syndromes, and neoplasia. Signal-dependent translation in activated neutrophils may be a critical mechanism for alteration of the inflammatory milieu and a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118085      PMCID: PMC406468          DOI: 10.1073/pnas.0401901101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Translation control: bridging the gap between genomics and proteomics?

Authors:  B Pradet-Balade; F Boulmé; H Beug; E W Müllner; J A Garcia-Sanz
Journal:  Trends Biochem Sci       Date:  2001-04       Impact factor: 13.807

Review 2.  TOR, a central controller of cell growth.

Authors:  T Schmelzle; M N Hall
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Why we don't get sick: the within-host population dynamics of bacterial infections.

Authors:  B R Levin; R Antia
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

4.  Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

Authors:  V Modur; M J Feldhaus; A S Weyrich; D L Jicha; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

Review 6.  Regulation of translation initiation by FRAP/mTOR.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

Review 7.  Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses.

Authors:  O Chertov; D Yang; O M Howard; J J Oppenheim
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

8.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation.

Authors:  S M Hurst; T S Wilkinson; R M McLoughlin; S Jones; S Horiuchi; N Yamamoto; S Rose-John; G M Fuller; N Topley; S A Jones
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

Review 9.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

10.  Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.

Authors:  S Lindemann; N D Tolley; D A Dixon; T M McIntyre; S M Prescott; G A Zimmerman; A S Weyrich
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

View more
  30 in total

1.  Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants.

Authors:  Nathan L Thornton; Mark J Cody; Christian C Yost
Journal:  Neonatology       Date:  2011-09-23       Impact factor: 4.035

Review 2.  Neutrophils cascading their way to inflammation.

Authors:  Christian D Sadik; Nancy D Kim; Andrew D Luster
Journal:  Trends Immunol       Date:  2011-08-11       Impact factor: 16.687

3.  mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

Authors:  Andrew S Weyrich; Melvin M Denis; Hansjorg Schwertz; Neal D Tolley; Jason Foulks; Eliott Spencer; Larry W Kraiss; Kurt H Albertine; Thomas M McIntyre; Guy A Zimmerman
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

4.  Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets.

Authors:  Melvin M Denis; Neal D Tolley; Michaeline Bunting; Hansjörg Schwertz; Huimiao Jiang; Stephan Lindemann; Christian C Yost; Frederick J Rubner; Kurt H Albertine; Kathryn J Swoboda; Carolyn M Fratto; Emilysa Tolley; Larry W Kraiss; Thomas M McIntyre; Guy A Zimmerman; Andrew S Weyrich
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

Review 5.  Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.

Authors:  Guy A Zimmerman; Andrew S Weyrich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

Review 6.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

7.  Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.

Authors:  Michael B Fessler; Patrick G Arndt; Ingo Just; Jerry A Nick; Kenneth C Malcolm; G Scott Worthen
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

8.  Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.

Authors:  Kelly L Singel; Tiffany R Emmons; Anm Nazmul H Khan; Paul C Mayor; Shichen Shen; Jerry T Wong; Kayla Morrell; Kevin H Eng; Jaron Mark; Richard B Bankert; Junko Matsuzaki; Richard C Koya; Anna M Blom; Kenneth R McLeish; Jun Qu; Sanjay Ram; Kirsten B Moysich; Scott I Abrams; Kunle Odunsi; Emese Zsiros; Brahm H Segal
Journal:  JCI Insight       Date:  2019-03-07

Review 9.  Eicosanoids in the innate immune response: TLR and non-TLR routes.

Authors:  Yolanda Alvarez; Isela Valera; Cristina Municio; Etzel Hugo; Francisco Padrón; Lydia Blanco; Mario Rodríguez; Nieves Fernández; Mariano Sánchez Crespo
Journal:  Mediators Inflamm       Date:  2010-06-15       Impact factor: 4.711

Review 10.  Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Authors:  Jean-Michel Dayer; Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2009-10-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.